microbio 2125 unit 6 part 24 - Ebola Virus Disease (EVD) and Marburg Virus Disease (MVD)

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/10

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

11 Terms

1
New cards

Etiological Agent: of ebola

genus Ebolavirus (ebola virus disease (EVD))filovirus

2
New cards

Etiological Agent: of marbug

genus MarburgVirus ( marbug virus Disease (MVD)) filovirus

3
New cards

Distinguishing characteristics of etiological agent:

  • Enveloped, filamentous (thread-like) virus

  • Nonsegmented, negative-sense ssRNA virus

  • Requires Biosafety Level 4 containment

  • Animal reservoirs (likely bats)

Cause viral hemorrhagic fevers

4
New cards

Virulence Factor(s):

  • Rapid replication and systemic spread

  • Induction of massive cytokine release ("cytokine storm")

  • Severe disruption of vascular integrity leading to hemorrhage

  • Immunosuppression and direct cytotoxic effects on host tissues

5
New cards

Predisposing Factors:

  • Contact with infected bodily fluids

  • Handling infected animals (e.g., fruit bats, non-human primates)

  • Lack of access to protective equipment or healthcare

6
New cards

Transmission:

  • Direct contact with blood, bodily fluids, or tissues of infected individuals

  • Contaminated medical equipment

  • Nosocomial spread (healthcare settings)

  • Not airborne, but highly infectious via fluids

  • Animal reservoirs

  • can be contracted from bats

7
New cards

Syndrome (signs + symptoms):

  • Early: Fever, headache, vomiting, diarrhea

  • Later: Hemorrhagic diathesis (severe internal and external bleeding)

  • Bleeding from eyes, nose, mouth, and other orifices

  • Death often occurs by 10 days post-infection due to multi-organ failure and shock

8
New cards

Affected body region/system:

  • Vascular system (extensive hemorrhage and clotting defects)

  • Liver (necrosis)

  • Immune system (severe suppression)

  • Multiple organ systems affected

9
New cards

Treatment:

introduction of coagulating factors, maintenance of O2 and blood levels

10
New cards

Prevention:

  • Ervebo vaccine (effective for Zaire ebolavirus)

  • no vaccine for marbug virus yet

  • Experimental vaccines in development for other strains

  • Strict infection control procedures and use of PPE

  • Avoid contact with infected animals or human remains

  • Quarantine and isolation of suspected cases

11
New cards

Other notes:

  • Mortality rate ranges from 80–90% in many outbreaks

  • Outbreaks usually occur in sub-Saharan Africa

  • Fast and coordinated response essential to containment

  • Marburg virus is similar in structure and pathology but has fewer outbreaks documented